38 devices · GMDN 41271
Multiple antinuclear antibody (ANA) screening IVDs are in vitro diagnostic controls designed to validate the accuracy and reliability of tests that detect ANAs in patient samples. Clinically, these controls ensure proper functioning of screening assays, helping confirm whether a test system is performing as intended before diagnosing autoimmune conditions like lupus or rheumatoid arthritis.
These controls are typically regulated as diagnostic devices and must meet performance standards to ensure clinical validity. They are often supplied as part of a kit or separately, depending on the manufacturer’s design, and are essential for maintaining lab quality and test consistency in autoimmune disease screening workflows.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.